Published in Viral Immunol on January 01, 2000
Epitope-blocking enzyme-linked immunosorbent assays for the detection of serum antibodies to west nile virus in multiple avian species. J Clin Microbiol (2003) 3.05
West Nile virus in overwintering Culex mosquitoes, New York City, 2000. Emerg Infect Dis (2001) 2.48
Epitope-blocking enzyme-linked immunosorbent assays for detection of west nile virus antibodies in domestic mammals. J Clin Microbiol (2003) 2.31
Viral encephalitis in England, 1989-1998: what did we miss? Emerg Infect Dis (2003) 2.26
Detection of human anti-flavivirus antibodies with a west nile virus recombinant antigen microsphere immunoassay. J Clin Microbiol (2004) 1.59
Transmission dynamics of an insect-specific flavivirus in a naturally infected Culex pipiens laboratory colony and effects of co-infection on vector competence for West Nile virus. Virology (2012) 1.35
Risk factors associated with human infection during the 2006 West Nile virus outbreak in Davis, a residential community in northern California. Am J Trop Med Hyg (2008) 1.24
Insect-specific flaviviruses from Culex mosquitoes in Colorado, with evidence of vertical transmission. Am J Trop Med Hyg (2011) 1.21
Surveillance of above- and below-ground mosquito breeding habitats in a rural midwestern community: baseline data for larvicidal control measures against West Nile Virus vectors. Clin Med Res (2005) 1.14
Evaluation of a diagnostic algorithm using immunoglobulin M enzyme-linked immunosorbent assay to differentiate human West Nile Virus and St. Louis Encephalitis virus infections during the 2002 West Nile Virus epidemic in the United States. Clin Diagn Lab Immunol (2004) 1.14
Seasonal patterns for entomological measures of risk for exposure to Culex vectors and West Nile virus in relation to human disease cases in northeastern Colorado. J Med Entomol (2009) 1.13
Detection of anti-West Nile virus immunoglobulin M in chicken serum by an enzyme-linked immunosorbent assay. J Clin Microbiol (2003) 0.95
Modeling dynamics of culex pipiens complex populations and assessing abatement strategies for West Nile Virus. PLoS One (2014) 0.81
Surveillance for West Nile virus in clinic-admitted raptors, Colorado. Emerg Infect Dis (2007) 0.80
Rapid West Nile virus antigen detection. Emerg Infect Dis (2005) 0.78
Neurologic aspects of infections in international travelers. Neurologist (2005) 0.77
Establishment of an Algorithm Using prM/E- and NS1-Specific IgM Antibody-Capture Enzyme-Linked Immunosorbent Assays in Diagnosis of Japanese Encephalitis Virus and West Nile Virus Infections in Humans. J Clin Microbiol (2015) 0.75
Comparison of the efficiency and cost of West Nile virus surveillance methods in California. Vector Borne Zoonotic Dis (2015) 0.75
West Nile virus in Ontario, Canada: A twelve-year analysis of human case prevalence, mosquito surveillance, and climate data. PLoS One (2017) 0.75
Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science (1999) 18.55
Rapid detection of west nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay. J Clin Microbiol (2000) 13.34
Nipah virus: a recently emergent deadly paramyxovirus. Science (2000) 9.39
Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J Clin Microbiol (2000) 8.80
West Nile encephalitis epidemic in southeastern Romania. Lancet (1998) 7.73
Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet (2001) 6.49
Pathology of fatal West Nile virus infections in native and exotic birds during the 1999 outbreak in New York City, New York. Vet Pathol (2000) 6.46
Crow deaths as a sentinel surveillance system for West Nile virus in the northeastern United States, 1999. Emerg Infect Dis (2001) 5.83
Cell membrane-binding properties of group A streptococcal lipoteichoic acid. J Exp Med (1975) 5.30
Detection of anti-arboviral immunoglobulin G by using a monoclonal antibody-based capture enzyme-linked immunosorbent assay. J Clin Microbiol (2000) 4.61
Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J Virol (2001) 4.27
Climate variability and change in the United States: potential impacts on vector- and rodent-borne diseases. Environ Health Perspect (2001) 3.69
Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53. Virology (1997) 3.48
West Nile virus: a reemerging global pathogen. Emerg Infect Dis (2001) 3.27
Identification of epitopes on the E glycoprotein of Saint Louis encephalitis virus using monoclonal antibodies. Virology (1983) 3.24
New mouse model for dengue virus vaccine testing. J Virol (1999) 3.18
Competence of American robins as reservoir hosts for Lyme disease spirochetes. Emerg Infect Dis (2000) 2.87
Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5'-noncoding region and the E2 envelope glycoprotein. J Virol (1993) 2.69
Diagnosis of early Lyme disease by polymerase chain reaction amplification and culture of skin biopsies from erythema migrans lesions. J Clin Microbiol (1992) 2.69
Widespread West Nile virus activity, eastern United States, 2000. Emerg Infect Dis (2001) 2.52
The Murray Valley encephalitis virus prM protein confers acid resistance to virus particles and alters the expression of epitopes within the R2 domain of E glycoprotein. Virology (1992) 2.48
Tick-borne diseases in the United States. N Engl J Med (1993) 2.39
Quality of life of African-American and white long term breast carcinoma survivors. Cancer (1999) 2.39
Breast cancer survivors: psychosocial concerns and quality of life. Breast Cancer Res Treat (1996) 2.35
The emergence of West Nile virus in North America: ecology, epidemiology, and surveillance. Curr Top Microbiol Immunol (2002) 2.27
Peptic digestion of streptococcal M protein. II. Extraction of M antigen from group A streptococci with pepsin. Infect Immun (1974) 2.18
Managing menopausal symptoms in breast cancer survivors: results of a randomized controlled trial. J Natl Cancer Inst (2000) 2.15
Experimental infection of chickens as candidate sentinels for West Nile virus. Emerg Infect Dis (2001) 2.14
Genetic heterogeneity of Borrelia burgdorferi in the United States. J Infect Dis (1997) 2.04
Risk factors for West Nile virus infection and meningoencephalitis, Romania, 1996. J Infect Dis (1999) 2.03
YKL-40, a secreted glycoprotein, promotes tumor angiogenesis. Oncogene (2009) 1.97
Mayaro virus disease: an emerging mosquito-borne zoonosis in tropical South America. Clin Infect Dis (1999) 1.93
Surveillance for Lyme disease--United States, 1992-1998. MMWR CDC Surveill Summ (2000) 1.91
apbA, a new genetic locus involved in thiamine biosynthesis in Salmonella typhimurium. J Bacteriol (1994) 1.84
Questionable efficacy of confidential unit exclusion. Transfusion (1990) 1.81
Antigenic analysis of the surface glycoproteins of a Venezuelan equine encephalomyelitis virus (TC-83) using monoclonal antibodies. Virology (1982) 1.80
West Nile virus outbreak among horses in New York State, 1999 and 2000. Emerg Infect Dis (2001) 1.76
Biliary complications in the treatment of unsubstantiated Lyme disease. J Infect Dis (1995) 1.74
Comparative West Nile virus detection in organs of naturally infected American Crows (Corvus brachyrhynchos). Emerg Infect Dis (2001) 1.73
Evaluation of phenotypic and genotypic methods for subtyping Campylobacter jejuni isolates from humans, poultry, and cattle. J Clin Microbiol (2000) 1.66
Pyruvate carboxylase: an astrocyte-specific enzyme implicated in the replenishment of amino acid neurotransmitter pools. Brain Res (1985) 1.62
The neutralization site on the E2 glycoprotein of Venezuelan equine encephalomyelitis (TC-83) virus is composed of multiple conformationally stable epitopes. Virology (1985) 1.62
Determination of the protective epitopes on the glycoproteins of Venezuelan equine encephalomyelitis virus by passive transfer of monoclonal antibodies. J Immunol (1982) 1.60
Changing epidemiology of Q fever in Germany, 1947-1999. Emerg Infect Dis (2001) 1.58
Elucidation of the topography and determination of the protective epitopes on the E glycoprotein of Saint Louis encephalitis virus by passive transfer with monoclonal antibodies. J Immunol (1984) 1.58
Selection and partial characterization of dengue 2 virus mutants that induce fusion at elevated pH. Virology (1993) 1.56
West Nile virus in livestock and wildlife. Curr Top Microbiol Immunol (2002) 1.56
The economic burden imposed by a residual case of eastern encephalitis. Am J Trop Med Hyg (1995) 1.55
Culex flavivirus isolates from mosquitoes in Guatemala. J Med Entomol (2008) 1.55
Quality of life in the first year after breast cancer surgery: rehabilitation needs and patterns of recovery. Breast Cancer Res Treat (1999) 1.54
Identification of a developmental program using bromodeoxyuridine. J Mol Biol (1972) 1.46
Venezuelan equine encephalitis and Oropouche virus infections among Peruvian army troops in the Amazon region of Peru. Am J Trop Med Hyg (1997) 1.45
The role of pathology in an investigation of an outbreak of West Nile encephalitis in New York, 1999. Emerg Infect Dis (2000) 1.43
Arbovirus infection increases with group size. Proc Biol Sci (2001) 1.41
Calculation of evolutionary trees from sequence data. Proc Natl Acad Sci U S A (1979) 1.41
Surveillance for pneumonic plague in the United States during an international emergency: a model for control of imported emerging diseases. Emerg Infect Dis (1996) 1.40
Bone mineral density and adjuvant therapy in breast cancer survivors. Breast Cancer Res Treat (2004) 1.40
Wicking assays for the rapid detection of West Nile and St. Louis encephalitis viral antigens in mosquitoes (Diptera: Culicidae). J Med Entomol (2003) 1.40
West Nile encephalitis in Israel, 1999: the New York connection. Emerg Infect Dis (2001) 1.39
Plague in India: a new warning from an old nemesis. Ann Intern Med (1995) 1.39
Immunoglobulin deficiency and regional enteritis. Scand J Gastroenterol (1972) 1.37
Characteristics of women at risk for psychosocial distress in the year after breast cancer. J Clin Oncol (1993) 1.35
OPUS study: suicidal behaviour, suicidal ideation and hopelessness among patients with first-episode psychosis. One-year follow-up of a randomised controlled trial. Br J Psychiatry Suppl (2002) 1.35
The envelope glycoproteins of dengue 1 and dengue 2 viruses grown in mosquito cells differ in their utilization of potential glycosylation sites. Virology (1994) 1.33
An interstate outbreak of tick-borne relapsing fever among vacationers at a Rocky Mountain cabin. Am J Trop Med Hyg (1998) 1.33
Predictors and reasons for relapse in smoking cessation with nicotine and placebo patches. Prev Med (1993) 1.33
Monoclonal antibodies against the flavivirus West Nile. J Gen Virol (1982) 1.33
Venezuelan equine encephalitis febrile cases among humans in the Peruvian Amazon River region. Am J Trop Med Hyg (1998) 1.30
Detection of St. Louis encephalitis virus antigen in mosquitoes by capture enzyme immunoassay. J Clin Microbiol (1987) 1.29
Isolation and characterization of hybrid cell lines producing monoclonal antibodies directed against the structural proteins of Sindbis virus. Virology (1980) 1.28
Isolation of glial cell-enriched and -depleted populations from mouse cerebellum by density gradient centrifugation and electronic cell sorting. Brain Res (1977) 1.26
Variants of Venezuelan equine encephalitis virus that resist neutralization define a domain of the E2 glycoprotein. Virology (1990) 1.25
Development of an enzyme-linked immunosorbent assay for the identification of arthropod-borne togavirus antibodies. J Gen Virol (1982) 1.24
Improved clarity of meaning from the use of both formal species names and common (vernacular) virus names in virological literature. Arch Virol (2002) 1.22
Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis. J Infect Dis (1994) 1.18
Role of complement and the Fc portion of immunoglobulin G in immunity to Venezuelan equine encephalomyelitis virus infection with glycoprotein-specific monoclonal antibodies. J Virol (1985) 1.18
EBV reactivation and post transplant lymphoproliferative disorders following allogeneic SCT. Bone Marrow Transplant (2008) 1.17
Identification of Highlands J virus from a Florida horse. Am J Trop Med Hyg (1988) 1.16
Emergence of Lyme disease in Hunterdon County, New Jersey, 1993: a case-control study of risk factors and evaluation of reporting patterns. Am J Epidemiol (1998) 1.14
Integrated treatment ameliorates negative symptoms in first episode psychosis--results from the Danish OPUS trial. Schizophr Res (2005) 1.14
Biochemical and biological characteristics of epitopes on the E1 glycoprotein of western equine encephalitis virus. Virology (1985) 1.12
Use of a novel technique of cutaneous lavage for diagnosis of Lyme disease associated with erythema migrans. JAMA (1992) 1.12
An outbreak of sheep-associated Q fever in a rural community in Germany. Eur J Epidemiol (1998) 1.11
Recombinant vaccinia virus/Venezuelan equine encephalitis (VEE) virus protects mice from peripheral VEE virus challenge. J Virol (1988) 1.10
A single amino acid change in the E2 glycoprotein of Venezuelan equine encephalitis virus affects replication and dissemination in Aedes aegypti mosquitoes. J Gen Virol (1991) 1.10
Properties of monoclonal antibodies directed against the glycoproteins of Sindbis virus. J Gen Virol (1982) 1.09
Backwards signing and ASL syllable structure. Lang Speech (1997) 1.08
Stability of St. Louis encephalitis viral antigen detected by enzyme immunoassay in infected mosquitoes. J Clin Microbiol (1988) 1.08
Culture-confirmed reinfection of a person with different strains of Borrelia burgdorferi sensu stricto. J Clin Microbiol (1998) 1.07
Making effective use of tumor registries for cancer survivorship research. Cancer (2001) 1.06
Predisposing factors for individuals' Lyme disease prevention practices: Connecticut, Maine, and Montana. Am J Public Health (1997) 1.06
Synthetic peptides of the E2 glycoprotein of Venezuelan equine encephalomyelitis virus. II. Antibody to the amino terminus protects animals by limiting viral replication. Virology (1991) 1.05
Waist circumference in relation to history of amount and type of alcohol: results from the Copenhagen City Heart Study. Int J Obes Relat Metab Disord (2003) 1.04